Business
Why is the Recce (ASX:RCE) share price in the red today?
The Recce Pharmaceuticals Ltd (ASX: RCE) share price has spent today in the red despite the company releasing positive data from anti-infective drug trials against bacterial sinusitis in mice.
It seems shareholders weren’t excited by the results, with the Recce share price dropping from its opening price of 98 cents to close at 97 cents.
Recce is a drug discovery and development business that produces synthetic antibiotics to address the global health challenge of antibiotic-resistant superbugs.
Recce report shows positive sinusitis fight
Recce’s data is from a large trial involving a total of 12 groups of 10 mice each. The study was performed to reveal the efficacy of a new anti-infective formulation, called RECCE 111…
-
General18 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News24 hours agoAustralia’s most disaster-prone state urged to prepare ahead of storm, flood and fire season
-
General23 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Business21 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?